Blog

How Robotics, Catheter Innovation, AI Diagnostics and Home-Based Care Are Reshaping the Medical Device Industry

Mobility Foresights Healthcare & Life Sciences Research | Hub Analysis | September 2026

The medical technology industry is being reshaped by three shifts at once:

• Care is moving out of the hospital. Procedures are shifting to ambulatory surgery centers, and monitoring and dialysis are moving into patients' homes.
• Procedures are becoming less invasive and more precise. This is visible in robotic joint replacement, pulsed field ablation, drug-coated balloons and transcatheter valve repair.
• Diagnosis is becoming AI-assisted. The FDA has now authorized more than 1,000 AI-enabled medical devices, most of them in radiology.

This hub brings together 69 Mobility Foresights market studies across seven areas: orthopedic implants and surgical robotics; cardiovascular and endovascular devices; endoscopy and visualization; dialysis, infusion and hospital equipment; neuromodulation and therapeutic devices; diagnostic imaging and AI; and digital health and remote monitoring.

Key Takeaways

• Robotics is becoming the standard of care in joint replacement. Growth is supported by the migration of knee and hip replacement to outpatient surgery centers.
• Electrophysiology and interventional cardiology are in a technology upgrade cycle. Pulsed field ablation, drug-coated balloons for in-stent restenosis and transcatheter repair are driving it.
• AI is being embedded directly into devices. Endoscopes, CT and mammography systems and pathology scanners now ship with AI rather than selling it as a separate product.
• Home-based care is a policy priority. Home dialysis, remote monitoring and hospital-at-home programs are shifting device demand toward connected, patient-operated equipment.
• Cybersecurity is now a device requirement. U.S. premarket cybersecurity rules apply to networked imaging and monitoring systems.

How We Segment MedTech and Digital Health

1. Orthopedic Implants and Surgical Robotics

Knee and hip replacement are among the highest-volume elective procedures, and demand grows with population aging and obesity. Four reports cover primary and revision surgery:

• Our primary knee systems market and primary hip systems market reports size first-time joint replacement.
• The revision knee systems market and revision hip systems market studies cover revision surgery, which grows as the installed base of implants ages and patients receive joints at younger ages.

Robotics has become the key competitive platform. Robotic systems are now the standard competitive offering among the leading orthopedic companies. The robotic knee arthroplasty systems market report covers system placements, procedure penetration and the pull-through of implant sales. The handheld surgical robot market study covers smaller, lower-cost handheld and image-free systems suited to ambulatory surgery centers. That setting has grown since Medicare allowed knee and hip replacement to be performed there.

Three reports cover newer implant designs and infection control:

• The stemless shoulder implant systems market report covers bone-preserving shoulder designs.
• The elbow fracture fixation systems market study covers anatomically contoured plates for complex fractures.
• The antibiotic bone cement market report covers cement loaded with antibiotics to prevent and treat periprosthetic joint infection, one of the most costly complications in orthopedics.

2. Cardiovascular and Endovascular Devices

Electrophysiology is in a rapid technology transition. Pulsed field ablation, approved in the U.S. from late 2023, uses electrical pulses rather than heat or cold to isolate cardiac tissue in atrial fibrillation. It has quickly gained share because of procedure speed and safety. Our flexible tip ablation catheter market report covers contact-force-sensing and flexible-tip ablation catheters within this changing competitive landscape.

Coronary intervention is also changing. The first coronary drug-coated balloon for in-stent restenosis was approved in the U.S. in 2024, giving physicians an option that avoids adding another layer of stent. Four reports cover the segment:

• The coronary in-stent restenosis market report sizes this segment.
• The coronary balloons market study covers the full balloon category.
• The guiding catheters market and coronary microcatheters market reports cover the access tools used in complex coronary intervention.
• The radial artery compression devices market study covers hemostasis devices for wrist access, now the preferred route for many coronary procedures because of lower bleeding risk.

Structural heart and vascular therapies complete the segment:

• The transcatheter clip device market report covers edge-to-edge repair for mitral and tricuspid regurgitation, extended to the tricuspid valve in the U.S. in 2024.
• The computer-assisted vacuum thrombectomy system market study covers systems that remove clots from arteries and veins, a fast-growing alternative to thrombolytic drugs in pulmonary embolism and venous thrombosis.
• The endovascular catheter system market report sizes the broader endovascular catheter market.
• The abdominal stent-graft system market and thoracic stent grafts market studies cover endovascular aortic repair.
• The embolization microcatheters market report covers devices used to block blood vessels in interventional oncology, bleeding control and emerging uses such as knee and prostate embolization.

3. Endoscopy and Surgical Visualization

AI arrived in endoscopy earlier than in most device categories. Computer-aided polyp detection during colonoscopy was first authorized by the FDA in 2021 and has been shown to increase adenoma detection. Two reports cover the field:

• Our AI in endoscopy market report covers the software, platforms and reimbursement environment.
• The AI endoscopy medical device market study covers the hardware side: endoscopes and processors with built-in AI.

Imaging quality and single-use design are the other trends:

• The 4K laparoscopic system market report covers ultra-high-definition and 3D visualization towers for minimally invasive surgery.
• The flexible ureteroscopes market study covers kidney-stone procedures, where single-use scopes have grown because they remove the repair costs and reprocessing risks of reusable devices.
• The ENT video endoscopes market and gynecological visualization system market reports cover specialty endoscopy in otolaryngology and gynecology, both increasingly performed in the office rather than the operating room.

4. Dialysis, Infusion and Hospital Equipment

Kidney care is a policy-driven device market. U.S. programs launched since 2019 aim to move more patients to home dialysis and transplantation. Our smart dialysis and home renal care technologies market report covers connected home hemodialysis and peritoneal dialysis systems. Five reports cover the equipment and consumables:

• The peritoneal dialysis cycler systems market and peritoneal dialysis catheters market reports cover home peritoneal dialysis.
• The hemodialysis dialyzers and filters market study covers dialyzers and filters.
• The bicarbonate dialysis concentrates market report covers dialysis concentrates.
• The CRRT replacement fluids market study covers continuous renal replacement therapy in intensive care.

Infusion is a high-volume consumables market with real supply-chain risk. A hurricane shut a major U.S. IV fluid plant in 2024 and caused nationwide shortages. Three reports cover infusion consumables:

• The gravity infusion sets market report covers gravity infusion sets.
• The winged infusion sets market study covers winged infusion sets.
• The high-pressure IV tubing market report covers tubing for contrast injection and critical care.

Four reports cover the wider hospital equipment base:

• The plasma collection systems market report covers apheresis devices at plasma centers.
• The blood processing storage equipment market study covers blood-bank equipment.
• The sequential compression device (SCD) market report covers devices that prevent venous thromboembolism in hospitalized and post-surgical patients.
• The medical humidifier market study covers humidification for respiratory therapy and ventilation.

5. Neuromodulation and Therapeutic Devices

Neuromodulation is becoming closed-loop. Adaptive deep brain stimulation, which senses brain signals and adjusts stimulation automatically, received U.S. approval for Parkinson's disease in 2025. Our adaptive deep brain stimulation device market report covers this transition and the sensing platforms behind it. The non-invasive neuromodulation devices market study covers transcranial magnetic stimulation, external vagus nerve stimulation and other non-surgical therapies for depression, migraine and pain.

Four reports cover device-based therapies in other organs:

• The cardiac contractility modulation therapy market report covers implantable devices that deliver electrical signals to strengthen heart contraction in heart failure.
• The organ perfusion system market study covers machines that keep donor hearts, lungs and livers functioning outside the body. The technology has extended transport times and increased the number of usable organs.
• The cryosurgery devices market report covers freezing-based tissue ablation in oncology, dermatology and cardiology.
• The nanorobots in healthcare market study covers the early-stage field of microscale devices for targeted delivery and diagnostics.

6. Diagnostic Imaging and AI

Radiology is the largest application of medical AI, with most FDA-authorized AI devices falling in imaging. Our AI-assisted diagnostic imaging systems market report sizes AI across CT, MRI, X-ray and ultrasound. Three reports cover specific clinical uses:

• The AI-driven chest CT analysis market study covers lung-nodule detection and triage, which is growing with lung cancer screening programs.
• The AI-enabled screening devices for early cancer detection market report covers AI across screening modalities.
• The breast imaging and mammography systems market study covers screening equipment. U.S. rules requiring breast-density notification took effect in 2024.

Pathology is digitizing more slowly but steadily:

• The digital pathology imaging systems market report covers slide scanners and image management.
• The AI-assisted pathology devices market study covers algorithms that grade tumors and quantify biomarkers.
• The brain imaging neuroimaging market report covers MRI, PET and emerging modalities in neurology, a segment boosted by amyloid imaging for Alzheimer's therapy.
• The point-of-care diagnostic imaging market study covers handheld ultrasound and portable X-ray and MRI.

Workforce shortages are pushing imaging into the cloud:

• The tele-radiology imaging services market report covers remote reading services that address radiologist shortages.
• The remote diagnostic imaging platforms market study covers the platforms that route studies to available readers.
• The cloud-based medical imaging platforms market report covers the move of image archives and viewing to cloud infrastructure.
• The medical imaging cybersecurity market study addresses the risks this creates. FDA cybersecurity requirements for networked devices have applied to new submissions since 2023.

7. Digital Health and Remote Monitoring

Digital health is consolidating around products that integrate into clinical workflows and reimbursement. Two reports cover clinical decision support:

• Our AI-enabled clinical decision support systems market report covers the software and integration market.
• The AI-enabled clinical decision support market study provides the use-case view, covering sepsis alerts, deterioration prediction and diagnostic support.

Three reports cover care outside the hospital:

• The virtual ICU (vICU) and AI-assisted critical care market report covers remote intensivist coverage and AI monitoring.
• The remote post-surgical monitoring devices market study covers wearables and connected devices that support early discharge.
• The digital chronic disease management platforms market report covers diabetes, hypertension and heart-failure programs that combine devices, coaching and data.

Consumer-grade sensing is converging with clinical care. The first over-the-counter continuous glucose monitor was cleared in 2024. Four reports cover this convergence and patient access:

• The next-generation wearable medical devices market report covers wearable devices.
• The next-generation medical sensors market study covers the sensors inside them.
• The medical XR (AR/VR/MR) applications market report covers extended reality in surgical planning, training, rehabilitation and pain management.
• The digital front door and patient access technologies market study covers scheduling, triage and patient-engagement platforms.

Longevity medicine is an emerging, largely self-pay segment. The longevity clinic diagnostic equipment market report covers the imaging, body-composition and metabolic testing equipment used by longevity clinics. The biological age testing for longevity clinics market study covers epigenetic and multi-omic tests that estimate biological age.

Where Value Is Created: The MedTech Value Chain

Regional perspective

• United States. The largest device market and the lead market for robotics, electrophysiology and AI. Medicare payment rules largely determine adoption speed.
• Europe. The Medical Device Regulation (MDR) has raised evidence requirements and slowed some launches, while national health systems drive procurement.
• China. Volume-based procurement has sharply cut prices for orthopedic implants and coronary devices and is favoring domestic manufacturers.
• India and Southeast Asia. Fast-growing procedure volumes and price-sensitive demand, with rising local manufacturing.

What to Watch Through 2032

1. Pulsed field ablation share gains: how fast they erode thermal ablation, and which catheter platforms win.
2. Robotic adoption in ambulatory centers: lower-cost handheld systems could accelerate penetration.
3. AI reimbursement: dedicated payment for AI imaging and pathology algorithms would unlock broader adoption.
4. Home dialysis penetration: progress toward U.S. policy targets and the supply of connected home systems.
5. Closed-loop neuromodulation: adaptive brain stimulation outcomes and expansion beyond Parkinson's disease.

Frequently Asked Questions

What is driving growth in the medical device market?

Population aging, the shift of procedures to outpatient and home settings, less invasive technologies such as robotics and transcatheter therapies, and AI-enabled diagnostics are the main drivers.

Why is robotic knee replacement growing?

Robotic systems improve implant positioning and consistency, and manufacturers use them to win implant volume. The ability to perform knee replacement in ambulatory surgery centers has made smaller, lower-cost systems attractive.

What is pulsed field ablation?

Pulsed field ablation treats atrial fibrillation by using short electrical pulses to disable heart tissue, instead of heat or cold. It can shorten procedures and reduce injury to nearby structures, and it has gained share rapidly since U.S. approval.

How is AI used in endoscopy and radiology?

AI highlights possible polyps during colonoscopy, flags urgent findings on CT scans, detects nodules and supports mammography reading. Most FDA-authorized AI medical devices are in radiology.

Why is home dialysis being encouraged?

Home dialysis offers patients more flexibility and can improve quality of life. U.S. policy programs since 2019 have encouraged providers to increase home dialysis and transplantation rates.

Why does medical imaging need cybersecurity?

Imaging systems and archives are networked and hold sensitive data, making them targets for ransomware. The FDA requires cybersecurity documentation for new connected devices.

What do Mobility Foresights MedTech reports include?

Each linked report provides market size and multi-year forecasts, growth drivers and challenges, segmentation by product, application, end user and region, competitive landscape and company profiles, and recent developments. Customization is available on request.

Work With Mobility Foresights

Mobility Foresights provides syndicated and custom research across medical devices, diagnostic imaging and digital health. Each report linked above can be purchased individually or tailored to a specific product, procedure, region or competitive question. Related analysis is available in our oncology and hematology therapeutics landscape. To request a sample or commission a bespoke study, contact our healthcare research team.